HEPATOCELLULAR CARCINOMA BY BCLC STAGE
Clinical trials for HEPATOCELLULAR CARCINOMA BY BCLC STAGE explained in plain language.
Never miss a new study
Get alerted when new HEPATOCELLULAR CARCINOMA BY BCLC STAGE trials appear
Sign up with your email to follow new studies for HEPATOCELLULAR CARCINOMA BY BCLC STAGE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough liver cancer cases
Disease control CompletedThis study tested a drug called tislelizumab for people with advanced liver cancer (hepatocellular carcinoma) who also had moderately weakened liver function (Child-Pugh B). The goal was to see if the drug, given alone, could effectively shrink tumors and control the cancer in th…
Matched conditions: HEPATOCELLULAR CARCINOMA BY BCLC STAGE
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
Researchers map Brazil's battle against liver cancer
Knowledge-focused CompletedThis study looked back at the medical records of 300 liver cancer patients treated in Brazilian hospitals between 2017 and 2022. The goal was to understand how liver cancer is typically managed in Brazil, what treatments patients receive, and how they fare over time. By analyzing…
Matched conditions: HEPATOCELLULAR CARCINOMA BY BCLC STAGE
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:56 UTC